Beijing Vitalstar Biotechnology Co., Ltd.(hereinafter referred to as VitalStar) is a high-tech company specializing in the research and development of genetically modified animal models and the provision of related products and technical services, which was established in 2000 under the advocacy of the National 863 Program, in order to promote the research and development and industrialization of animal models of diseases in China. We are a high-tech company specializing in the research and development of animal models of genetic modification and providing related products and technical services.
VitalStar has a team of technical talents led by overseas returnee PhDs and PhDs from famous universities in China, with more than 10 years of profound technical accumulation and experience in R&D and experimental operation in the field of model animal R&D. VitalStar has successfully established a mature and efficient technical platform for large-scale preparation of animal models of diseases, and has built a systematic and process-oriented operation mode for transgenic and knockout/knock-in technologies, it has a series of related technical service capabilities from gene cloning, vector construction to microinjection, phenotype identification, phenotype analysis and detection, cryopreservation and other related technical services. We have a series of related technical service capabilities from gene cloning, vector construction to microinjection, strain establishment, genotype identification, phenotype analysis and detection, cryopreservation and so on. At the same time, the company has also mastered CRISPR/Cas9-assisted gene editing, ES/EPS-based gene targeting, tetraploid embryo polymerization, mouse cloning and iPS cell-induced differentiation and other related technologies, which greatly improves the capacity and level of disease model research and development services. VitalStar has successfully produced nearly thousands types of genetically modified mice for domestic and foreign customers using this platform technology.
Committed to the development of rat and mouse models related to human disease research, comprehensively applying gene modification, surgery, physical and chemical induction to establish clinically relevant models, and to build a platform for in vitro and in vivo experiments and detection analysis technologies
VitalStar focus on building technological platforms with distinctive advantages, including population management, microinjection, (bioanalytical) testing, hepatocyte transplantation, and hematopoietic and immune cell transplantation platforms, equipped with high-precision hardware facilities such as microinjection systems, microimaging systems, multicolor flow cytometers, IVIS in vivo imaging systems, and ABSL-2 laboratories.